rs3754935

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000264275.9(CASP8):​c.-26-11912A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.131 in 152,166 control chromosomes in the GnomAD database, including 1,812 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.13 ( 1812 hom., cov: 32)

Consequence

CASP8
ENST00000264275.9 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.154

Publications

5 publications found
Variant links:
Genes affected
CASP8 (HGNC:1509): (caspase 8) This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes composed of a prodomain, a large protease subunit, and a small protease subunit. Activation of caspases requires proteolytic processing at conserved internal aspartic residues to generate a heterodimeric enzyme consisting of the large and small subunits. This protein is involved in the programmed cell death induced by Fas and various apoptotic stimuli. The N-terminal FADD-like death effector domain of this protein suggests that it may interact with Fas-interacting protein FADD. This protein was detected in the insoluble fraction of the affected brain region from Huntington disease patients but not in those from normal controls, which implicated the role in neurodegenerative diseases. Many alternatively spliced transcript variants encoding different isoforms have been described, although not all variants have had their full-length sequences determined. [provided by RefSeq, Jul 2008]
CASP8 Gene-Disease associations (from GenCC):
  • autoimmune lymphoproliferative syndrome type 2B
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.28 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000264275.9. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CASP8
NM_001228.5
c.-26-11912A>C
intron
N/ANP_001219.2
CASP8
NM_001400648.1
c.-26-11912A>C
intron
N/ANP_001387577.1
CASP8
NM_001400651.1
c.-26-11912A>C
intron
N/ANP_001387580.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CASP8
ENST00000264275.9
TSL:1
c.-26-11912A>C
intron
N/AENSP00000264275.5
CASP8
ENST00000392258.7
TSL:1
c.-26-11912A>C
intron
N/AENSP00000376087.3
CASP8
ENST00000471383.5
TSL:1
n.251-11912A>C
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.130
AC:
19832
AN:
152048
Hom.:
1807
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.234
Gnomad AMI
AF:
0.180
Gnomad AMR
AF:
0.0623
Gnomad ASJ
AF:
0.0948
Gnomad EAS
AF:
0.228
Gnomad SAS
AF:
0.292
Gnomad FIN
AF:
0.0525
Gnomad MID
AF:
0.207
Gnomad NFE
AF:
0.0775
Gnomad OTH
AF:
0.119
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.131
AC:
19870
AN:
152166
Hom.:
1812
Cov.:
32
AF XY:
0.133
AC XY:
9918
AN XY:
74406
show subpopulations
African (AFR)
AF:
0.234
AC:
9701
AN:
41488
American (AMR)
AF:
0.0622
AC:
951
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0948
AC:
329
AN:
3470
East Asian (EAS)
AF:
0.228
AC:
1175
AN:
5156
South Asian (SAS)
AF:
0.292
AC:
1410
AN:
4822
European-Finnish (FIN)
AF:
0.0525
AC:
557
AN:
10614
Middle Eastern (MID)
AF:
0.212
AC:
62
AN:
292
European-Non Finnish (NFE)
AF:
0.0775
AC:
5273
AN:
68012
Other (OTH)
AF:
0.118
AC:
248
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
855
1710
2566
3421
4276
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
224
448
672
896
1120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0959
Hom.:
3309
Bravo
AF:
0.134
Asia WGS
AF:
0.257
AC:
891
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.93
DANN
Benign
0.40
PhyloP100
-0.15
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3754935; hg19: chr2-202119272; API